Cáncer de mama precoz: el caso de la neoadyuvancia en HER2 positivo - page 8

Association of pCR with EFS in HER2+
Subtypes
Broglio K, et al. JAMA Oncol 2016
HR=0.29
HR=0.52
1,2,3,4,5,6,7 9,10,11,12,13,14,15,16,17,18,...47
Powered by FlippingBook